The fact that they maybe looking at cutting costs or that they have no inflows to pay their exorbitant fees?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025